Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Miravitlles

Showing results (391-400 of 565) with videos related to

Pageof 57
Sort By:
Thorax|September 4, 2020
Caring for patients with COPD and COVID-19: a viewpoint to spark discussionSami O Simons, John R Hurst, Marc Miravitlles, et al.
Human Genomics|June 5, 2023
Distribution of alpha1 antitrypsin rare alleles in six countries: Results from the Progenika diagnostic networkJosé Luis Lopez-Campos, Noelia Rapun, Karen Czischke, et al.
Respiratory Research|January 20, 2018
Chronic obstructive pulmonary disease guidelines in Europe: a look into the futureMarc Miravitlles, Nicolas Roche, João Cardoso, et al.
Archivos De Bronconeumologia|July 25, 2022
Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research CollaborationDavid G Parr, Joanna Chorostowska-Wynimko, Angelo Corsico, et al.
Respiratory Medicine|June 14, 2005
Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokersMarc Miravitlles, Montserrat Ferrer, Angels Pont, et al.
American Journal of Respiratory and Critical Care Medicine|December 16, 2024
Is Disease Stability an Attainable Chronic Obstructive Pulmonary Disease Treatment Goal?Dave Singh, MeiLan K Han, Surya P Bhatt, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 9, 2022
Discriminant Validity of a Single Clinical Question for the Screening of Inactivity in Individuals Living with COPDMaria Antonia Ramon, Cristóbal Esteban, Francisco Ortega, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 2, 2017
Self-reported daily walking time in COPD: relationship with relevant clinical and functional characteristicsMaria A Ramon, Cristina Esquinas, Miriam Barrecheguren, et al.
Therapeutic Advances in Respiratory Disease|July 14, 2016
Development of an enhanced health-economic model and cost-effectiveness analysis of tiotropium + olodaterol Respimat® fixed-dose combination for chronic obstructive pulmonary disease patients in ItalyCarl Selya-Hammer, Nuria Gonzalez-Rojas Guix, Michael Baldwin, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 2, 2019
Correlation between disease severity factors and EQ-5D utilities in chronic obstructive pulmonary diseaseCristina Esquinas, Maria A Ramon, Alexa Nuñez, et al.
Pageof 57

Showing results (391-400 of 565) with videos related to

Sort By:
Pageof 57
Thorax|September 4, 2020
Caring for patients with COPD and COVID-19: a viewpoint to spark discussionSami O Simons, John R Hurst, Marc Miravitlles, et al.
Human Genomics|June 5, 2023
Distribution of alpha1 antitrypsin rare alleles in six countries: Results from the Progenika diagnostic networkJosé Luis Lopez-Campos, Noelia Rapun, Karen Czischke, et al.
Respiratory Research|January 20, 2018
Chronic obstructive pulmonary disease guidelines in Europe: a look into the futureMarc Miravitlles, Nicolas Roche, João Cardoso, et al.
Archivos De Bronconeumologia|July 25, 2022
Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research CollaborationDavid G Parr, Joanna Chorostowska-Wynimko, Angelo Corsico, et al.
Respiratory Medicine|June 14, 2005
Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokersMarc Miravitlles, Montserrat Ferrer, Angels Pont, et al.
American Journal of Respiratory and Critical Care Medicine|December 16, 2024
Is Disease Stability an Attainable Chronic Obstructive Pulmonary Disease Treatment Goal?Dave Singh, MeiLan K Han, Surya P Bhatt, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 9, 2022
Discriminant Validity of a Single Clinical Question for the Screening of Inactivity in Individuals Living with COPDMaria Antonia Ramon, Cristóbal Esteban, Francisco Ortega, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 2, 2017
Self-reported daily walking time in COPD: relationship with relevant clinical and functional characteristicsMaria A Ramon, Cristina Esquinas, Miriam Barrecheguren, et al.
Therapeutic Advances in Respiratory Disease|July 14, 2016
Development of an enhanced health-economic model and cost-effectiveness analysis of tiotropium + olodaterol Respimat® fixed-dose combination for chronic obstructive pulmonary disease patients in ItalyCarl Selya-Hammer, Nuria Gonzalez-Rojas Guix, Michael Baldwin, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 2, 2019
Correlation between disease severity factors and EQ-5D utilities in chronic obstructive pulmonary diseaseCristina Esquinas, Maria A Ramon, Alexa Nuñez, et al.
Pageof 57